Page last updated: 2024-12-06

cetamolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID53698
CHEMBL ID156885
CHEBI ID135322
SCHEMBL ID79706
MeSH IDM0116878

Synonyms (23)

Synonym
cetamolol
CHEBI:135322
CHEMBL156885
2-[2-[3-(tert-butylamino)-2-hydroxypropoxy]phenoxy]-n-methylacetamide
34919-98-7
ici 72222
ici 72,222
cetamolol [inn]
cetamololum
cetamololum [inn-latin]
acetamide, 2-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-n-methyl-
z0vd1633o8 ,
unii-z0vd1633o8
cetamolol [mi]
acetamide, 2-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenoxy)-n-methyl-, (+/-)-
(+/-)-2-(o-(3-(tert-butylamino)-2-hydroxypropoxy)phenoxy)-n-methylacetamide
SCHEMBL79706
UWCBNAVPISMFJZ-UHFFFAOYSA-N
3-(o-n-methylcarbamoylmethoxyphenoxy)-1-t-butylaminopropan-2-ol
FT-0704099
Q15577539
ai27303; ai-27303; ai 27303; ici72222; ici-72222; ici 72222
DTXSID20865739

Research Excerpts

Overview

Cetamolol is a new beta-adrenoceptor blocking agent shown in animals to have moderate beta 1- adreno receptor selectivity and partial agonist activity.

ExcerptReferenceRelevance
"Cetamolol is a new beta-adrenoceptor blocking agent shown in animals to have moderate beta 1-adrenoceptor selectivity and partial agonist activity. "( Dynamics of beta-adrenoceptor blockade with cetamolol.
Coelho, J; Joubert, L; Mullane, J; Schnelle, K; Ventura, D, 1985
)
1.97

Pharmacokinetics

ExcerptReferenceRelevance
"The efficacy, safety, and pharmacokinetic parameters of a 30-mg oral dose of cetamolol hydrochloride (Betacor), a new synthetic cardioselective beta-adrenoceptor antagonist, with intrinsic sympathomimetic activity, were evaluated by studying 32 hypertensive patients with normal renal function or different degrees of renal impairment."( Pharmacokinetics of cetamolol in hypertensive patients with normal and compromised renal function.
Acchiardo, SA; Carter, CA; Ingebretsen, CG; Klausner, MA; Kraml, M; Lee, DK; Skoutakis, VA, 1988
)
0.83

Dosage Studied

ExcerptRelevanceReference
" Based on these findings, dosing recommendations are suggested for patients who have compromised renal function because of the effects of renal function on the pharmacokinetics of cetamolol."( Pharmacokinetics of cetamolol in hypertensive patients with normal and compromised renal function.
Acchiardo, SA; Carter, CA; Ingebretsen, CG; Klausner, MA; Kraml, M; Lee, DK; Skoutakis, VA, 1988
)
0.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.67%)4.05%
Observational0 (0.00%)0.25%
Other11 (73.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]